These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7033091)

  • 1. Calcium-antagonistic effects on glucose response to glucagon in patients with non insulin-dependent diabetes mellitus and in normoglycemic subjects.
    Röjdmark S; Andersson DE; Hed R; Sundblad L
    Horm Metab Res; 1981 Dec; 13(12):664-7. PubMed ID: 7033091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose lowering effect of verapamil in fasted man.
    Andersson DE; Röjdmark S
    Horm Metab Res; 1984 Dec; 16 Suppl 1():160-3. PubMed ID: 6398256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
    Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
    Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of verapamil on glucose, insulin and glucagon levels after oral glucose load in normal and diabetic subjects.
    Ferlito S; Modica L; Romano F; Patané M; Raudino M; Branca S; Costa A
    Panminerva Med; 1982; 24(3):221-6. PubMed ID: 6757844
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and hormonal responses during a glucose controlled insulin infusion (Biostator) in subjects with impaired glucose tolerance.
    Ratzmann KP; Schneider U; Peters U; Ziegler M; Schulz B
    Exp Clin Endocrinol; 1984 May; 83(3):334-42. PubMed ID: 6381073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in plasma glucagon concentration in patients with diabetes mellitus and its clinical significance].
    Tang S
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):222-4, 255. PubMed ID: 1327451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man.
    Andersson DE; Röjdmark S; Hed R; Sundblad L
    Acta Med Scand; 1982; 211(1-2):35-43. PubMed ID: 7041521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of verapamil on glucose response to intravenous injection of glucagon and insulin in healthy subjects.
    Röjdmark S; Andersson DE; Hed R; Sundblad L
    Horm Metab Res; 1980 Jul; 12(7):285-90. PubMed ID: 6995247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of verapamil on glucose response to glucagon during intravenous infusion of somatostatin.
    Andersson DE; Röjdmark S; Hed R; Sundblad L
    Horm Metab Res; 1980 Oct; 12(10):554-5. PubMed ID: 6108286
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus.
    Andersson DE; Röjdmark S
    Acta Med Scand; 1981; 210(1-2):27-33. PubMed ID: 7027745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcitonin on the glucose and insulin responses to glucagon in normal and diabetic subjects.
    Ferlito S; Del Campo F; Damante G; Di Vincenzo S; Romano F; Ciulla P; Patanè M
    Farmaco Prat; 1982 Jul; 37(7):239-44. PubMed ID: 6751866
    [No Abstract]   [Full Text] [Related]  

  • 14. Amino acid modulation of glucose-induced insulin and glucagon release in diabetic patients.
    Seino Y; Ikeda M; Nakane K; Nakahara H; Seino S
    Metabolism; 1977 Aug; 26(8):911-9. PubMed ID: 875735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
    Starke A; Keck E; Berger M; Zimmermann H
    Diabetologia; 1981 May; 20(5):547-52. PubMed ID: 7026328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of verapamil on the metabolic action of glucagon.
    Ferlito S; Del Campo F; Damante G; Di Vincenzo S; Costa A; Branca S
    Horm Metab Res; 1982 Nov; 14(11):611. PubMed ID: 6759354
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.
    De Marinis L; Barbarino A
    Metabolism; 1980 Jul; 29(7):599-604. PubMed ID: 6247604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of calcium antagonists on pancreatic endocrine secretion].
    Vincenzi V; Fioroni E; Benvegnù B; De Angelis M; Bartolucci L; Gradoli C; Valori C
    Minerva Med; 1985 May; 76(19-20):919-21. PubMed ID: 3889722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and hormone release. IV. The role of calcium in glucose-stimulated early phase insulin release in vivo.
    De Marinis L; Merlini G; Makhoul O; Barbarino A
    J Endocrinol Invest; 1982; 5(2):121-4. PubMed ID: 7047633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Glucagon and the regulation of blood sugar.
    Levine R
    N Engl J Med; 1976 Feb; 294(9):494-5. PubMed ID: 1246335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.